Dr. Nancy Carnide
Dr. Nancy Carnide is a scientist at the Institute for Work & Health. She is also an assistant professor in the Division of Epidemiology at the University of Toronto's Dalla Lana School of Public Health.
She has a PhD in epidemiology from the Dalla Lana School of Public Health at the University of Toronto. During her PhD, she was the recipient of a Canadian Institutes of Health Research (CIHR) Vanier Canada Graduate Scholarship and a CIHR Strategic Training Fellowship in Work Disability Prevention. Carnide was previously a post-doctoral fellow at the Institute.
Carnide conducts research at the intersection between occupational health and safety and substance use. Her research projects have involved analysis of survey and administrative data, as well as systematic reviews. Her program of research includes examining the use and non-medical use of prescription and recreational drugs among workers, their risk factors and the workplace consequences of their use, with a focus on cannabis and opioids.
“The gaps in knowledge around the scope, determinants and effects of substance use among workers are vast. Given the current opioid crisis and the move towards cannabis legalization in multiple jurisdictions, including Canada, I cannot think of a more timely area for research in occupational health and safety.” – Dr. Nancy Carnide
Projects
- Ontario Life After Work Injury Study: Understanding the long-term recovery and labour market outcomes of injured workers in the shadow of COVID-19. Funded by Workplace Safety and Insurance Board. Ongoing.
- Opioid-related harms among Ontario workers: a surveillance tool. Funded by Public Health Agency of Canada. Ongoing. (PI on the project)
- Project ECHO Occupational and Environmental Medicine (OEM): Implementation and evaluation. Funded by Workplace Safety and Insurance Board. Ongoing.
- Toking 9 to 5: Workplace cannabis use and perceptions among Canadian workers. Funded by Canadian Institutes of Health Research. Ongoing. (PI on the project)
- What are the long-term health and labour market outcomes of workers who experienced work-related COVID-19 transmission?. Funded by Canadian Institutes of Health Research (CIHR). Ongoing.
Publications
- Bultmann U, Franche RL, Hogg-Johnson S, Cote P, Lee H, Severin C, Vidmar M, Carnide N. Health status, work limitations, and return-to-work trajectories in injured workers with musculoskeletal disorders. Quality of Life Research. 2007;16(7):1167-1178. doi:10.1007/s11136-007-9229-x.
Speaker Series presentations
- Clearing the haze: Understanding how Canadian workers use and perceive cannabis at work. IWH Speaker Series. November 20, 2018.
Interviews and articles
- High at the helm: Workplaces preparing for cannabis legalization. The Globe and Mail. April 6, 2018. Available from: https://www.theglobeandmail.com/canada/british-columbia/article-high-at-the-helm-workplaces-preparing-for-cannabis-legalization/
- IWH Updates. At Work: Institute for Work & Health; No. 91, Winter 2018.
- Studies consistent in finding a link between opioids for MSDs and longer work disability. At Work: Institute for Work & Health; No. 91, Winter 2018.
- Marijuana in the workplace: What is unsafe?. The Conversation: The Conversation (Toronto, ON). January 22, 2018. Available from: https://theconversation.com/marijuana-in-the-workplace-what-is-unsafe-89142
- Companies fret about hazy rules around pot use. National Post: Postmedia Network (Toronto, ON). December 14, 2017. Available from: http://nationalpost.com/pmn/news-pmn/canada-news-pmn/companies-fret-about-hazy-rules-around-pot-use